CHM 0.00% 1.4¢ chimeric therapeutics limited

Ann: University of Pennsylvania joins CHM CDH17 Phase 1/2 trial, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 96 Posts.
    lightbulb Created with Sketch. 37
    initial PET scan for the first CDH17 patient will probably happen after 4 weeks. Obviously starting with a low dose, but would be awesome to see positive signs in respect to efficacy / pharmokinetics
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.